Jacobs SA, Lee JJ, George TJ, Wade JL, et al. Neratinib plus Cetuximab in Quadruple WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study. Clin Cancer Res 2020 Nov 17. pii: 1078-0432.CCR-20-1831.
PMID: 33203645